AMBOSS AI Mode vs UpToDate (2026)
AMBOSS AI Mode and UpToDate Expert AI turn curated clinical reference material into conversational answers. AMBOSS combines its library with guidelines and drug information; UpToDate draws its clinical answers exclusively from its own expert authored content and makes assumptions explicit. AMBOSS AI Mode Clinical Care links concise summaries to sources, highlights differing recommendations and can indicate insufficient information. Clinicians retain responsibility for interpretation. Individual membership costs $29.99 monthly, with AI access subject to rollout and possible future premium packaging. Current terms prohibit patient information, and chart context or structured writeback remain later development phases. The LiSA benchmark concerns consultation responses, not improved patient outcomes. UpToDate Expert AI opens answers with an Assumptions section and uses Nudges to request missing context. Inline citations, a rationale panel and Lexidrug information support review. It reaches individuals through eligible subscriptions and health systems through Enterprise Edition. Historical studies of the reference product do not validate the newer generative layer, whose independent performance evaluation remains limited. AMBOSS fits clinicians wanting AI questions alongside an existing reference membership and a workflow without patient data. UpToDate fits clinicians and institutions anchored in its content who want explicit assumptions and contextual prompts around generated answers. Both support professional judgment through reviewable reference material rather than autonomous treatment actions.
- An AMBOSS membership already supports clinical reference work.
- Answers should combine the library, guidelines and drug information.
- The workflow can exclude patient information from questions.
- A public monthly membership price is useful for individual access.
- The organization already relies on UpToDate reference content.
- Assumptions should be visible at the start of each answer.
- Missing clinical context should trigger inline prompts.
- Institutional access should follow the Enterprise Edition route.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. AMBOSS AI Mode and UpToDate are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | AMBOSS AI Mode | UpToDate |
|---|---|---|
| Primary category | Clinical Reference & Evidence | Clinical Reference & Evidence |
| Headquarters | Berlin, Germany | Waltham, Massachusetts |
| Website | amboss.com | wolterskluwer.com |
Side by Side
Select any grade to read the note behind it.
Each vendor in one paragraph
Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.
AMBOSS AI Mode Clinical Care answers medical questions with short summaries linked to selected sources. It draws on the edited AMBOSS library, US clinical guidelines and a drug database, adapting the presentation to a clinician's specialty. Answers can highlight conflicting recommendations and support follow up exploration of related evidence.
Source: AI Health Index, October 2026
Clinical reference and decision support published by Wolters Kluwer Health and in market for more than thirty years, with content curated by over 7,600 physician authors and editors and reported use by more than three million clinicians across thousands of hospitals worldwide.
Source: AI Health Index, October 2026
Questions buyers ask
How do AMBOSS AI Mode and UpToDate work with the EHR?
For AMBOSS AI Mode, a research preview demonstrates those later functions in a simulated EHR.
With UpToDate, patient education material is offered in up to nineteen languages, which is a real interoperability property in a multilingual health system. The company's release of 3 June 2026 states that more than half of United States Enterprise Edition customers, approximately 2,000 hospitals, had signed up for the Expert AI version by 30 April 2026, so the generative layer is reaching the chart through the same route. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified October 15, 2026. No vendor pays for placement.
How are AMBOSS AI Mode and UpToDate priced and sold?
AI Mode is currently included in AMBOSS subscriptions, with a possible future premium package disclosed. The site offers a five day trial, but AI access remains subject to rollout and a possible waiting period of several weeks.
For UpToDate, enterprise pricing, which is what a health system buys and the tier that reaches most clinicians, is gated behind a sales conversation. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified October 15, 2026. No vendor pays for placement.
How do AMBOSS AI Mode and UpToDate handle patient data?
Provider zero retention does not mean the AMBOSS application stores no input.
The terms of use state that UpToDate and its licensors are not intended to receive, transmit, store or process protected health information under HIPAA, which places the product outside the patient data relationship by contract. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified October 15, 2026. No vendor pays for placement.
Which settings and specialties do AMBOSS AI Mode and UpToDate cover?
For AMBOSS AI Mode, the NOHARM consultation benchmark spans 10 specialties but does not validate every advertised workflow or population. Selected reference content and responsive language support do not by themselves establish equal performance in rare diseases, pediatric contexts or every language.
With UpToDate, the trainee and medical university segments are substantial, and continuing medical education accrues inside the AI product, so the product serves workforce and training as well. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified October 15, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Reference & Evidence page.
AMBOSS is based in Berlin. UpToDate is a Wolters Kluwer Health product based in Waltham, Massachusetts. AMBOSS institutional licensing and UpToDate enterprise pricing require separate commercial discussions. Eligibility and AI inclusion vary by subscription and country.